SlideShare a Scribd company logo
Requirements for Standardized Study Data: 
Update on Guidance 
Ron Fitzmartin, PhD, MBA 
Data Standards Program 
Office of Strategic Programs 
Center for Drug Evaluation & Research 
Food and Drug Administration 
Presented at the 
CSS / PhUSE Meeting 
Silver Spring, MD 
17 March 2014
2 
Disclaimer 
The views and opinions presented here represent 
those of the speaker and should not be considered 
to represent advice or guidance on behalf of the 
Food and Drug Administration.
March, 2012 
3 
March, 2014
4 
Road to Required Electronic Standardized 
Study Data
6 
…no earlier than 24 
months after final 
guidance issued after 
public notice” 
[certain] submissions 
shall be submitted in 
such electronic 
format as specified 
by the Secretary in 
such guidance. 
… the [FDA] may—provide 
a timetable for 
establishment 
of further standards for 
electronic submission as 
required and set forth 
criteria for waivers of and 
exemptions 
from the requirements. 
FDASIA Statute* 
Authorized Required Electronic Submissions 
CDER 
CBER 
*FDASIA: FDA Safety & Innovation Act (2012)
FDASIA* Re-Authorized PDUFA V 
PDUFA V 
Goals –Section 
XII 
7 
“…develop 
standardized clinical 
data terminology 
through open 
standards 
development 
organizations (i.e., 
CDISC)” 
“… periodically publish 
final guidance specifying 
the completed data 
standards, formats, and 
terminologies that 
sponsors must use to 
submit data in 
applications.” 
*FDASIA: FDA Safety & Innovation Act (2012)
Re-Designed FDA Web Page 
8 
Quick access to 
Catalog, Guidance 
and Tech Guide 
http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm
Draft Binding Guidances & Tech Guide 
Published for Public Comment: 6 February 2014 
http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm 9
What is Binding Guidance? 
10 
Guidance = 
Binding 
Guidance = 
“Please” 
• Recommends, 
• Suggests, 
• Encourages 
• Requires 
Do it! 
Binding 
Guidance 
has a bite!
• Submission types: 
– NDAs, ANDAs, Certain BLAs & INDs 
• Submission not in the electronic 
format(s) specified in guidance will 
not be filed. 
• Electronic submissions are required 
no earlier than 24 months after a 
final guidance is issued. 
• Individual draft guidances will be 
developed. 
11 
FDASIA 745A(a) Guidance (1)
• Electronic submission of 
standardized study data 
required for: 
– Certain INDs 
– NDAs 
– ANDAs 
– Certain BLAs 
• Including amendments, 
supplements, and reports 
12 
eStudy Data Guidance (1)
• Study data must be submitted 
electronically or it will not be 
filed…unless exempt: 
– Devices regulated by CBER as 
biological products under Section 351 
of the PHS Act 
– Study data in noncommercial INDs 
(e.g., investigator-sponsored INDs, 
emergency use INDs, and treatment 
INDs). 
13 
eStudy Data Guidance (2)
• What are the requirements for 
Standardized Study Data? 
– Must be in a format that FDA can 
process, review, and archive. 
– Formats listed in the Data Standards 
Catalog (DSC). 
– DSC lists the supported and/or required 
standards. 
– DSC lists key dates for each standard. 
14 
eStudy Data Guidance (3) 
http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm
• What are the requirements for 
Standardized Study Data? 
– DSC lists (or will) dates when: 
• Support begins and ends 
• Requirement begins and ends 
• FDA may Refuse To File 
– If study data do not conform to the 
required standards, formats, and 
terminologies. 
15 
eStudy Data Guidance (4) 
http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm
Data Standards Catalog 
16 
eStudy Data Guidance (5) 
Dates: 
Requirement 
Begins & Ends
• Will there be waivers from the 
requirement? 
– No. 
– However, waivers may be granted to 
use specific (e.g., retired) versions of 
standards listed in the Data Catalog. 
17 
eStudy Data Guidance (6)
• Initial Timetable for Requirements 
– NDAs, ANDAs, certain BLA Submissions 
• Studies that start 24 months after publication of final 
eStudy Guidance. 
– Start Date defined as by CDISC SDTM Trial Summary 
Domain 
• Studies must use the standards, formats, 
terminologies posted in Data Standards Catalog. 
– Certain IND Submissions 
• Studies that start 36 months after publication of final 
eStudy Guidance. 
18 
eStudy Data Guidance (7)
• Initial Timetable for Requirement – Example 
– November 15, 2014 - Federal Register Notice of final 
eStudy Guidance 
• #1- Sponsor starts a study October 22, 2016 
– Submission of Standardized Study Data not required (but 
recommended) for that study. 
• #2- Sponsor starts a study December 3, 2016 
– Submission of Standardized Study Data will be required 
for that study. 
– Must use FDA-supported standards, formats and 
terminologies specified in the Data Standards Catalog. 
19 
eStudy Data Guidance (8)
• Version Updates 
– Types 
• Content or structural changes (e.g., new SDTM 
domains or variables). 
• Typographical errors, corrections, or clarifications. 
– Federal Register notice will specify the effective date 
and will correspond to a specific calendar month, e.g., 
March. 
– Required in submissions for studies starting no earlier 
than 12 months after the Federal Register notice. 
20 
eStudy Data Guidance (9)
• Version Updates – Example 
– May 6, 2016, Federal Register notice - support for 
new version, SDTM 4.1, and update to the Data 
Standards Catalog. 
• Effective date posted in the Federal Register notice is 
March 15, 2017. 
• Required in submissions for studies that start after 
March 15, 2018. 
• The Data Standards Catalog will list March 15, 2018 as 
the “date requirement begins.” 
21 
eStudy Data Guidance (10)
• New Standards 
– New standards, formats and terminologies 
• Not supported by FDA and 
• Not listed in the Data Standards Catalog when Guidance 
is final. 
– After notice in the Federal Register, required in 
submissions for studies that start 
• 24 months (NDAs, ANDAs, and certain BLAs) and 
• 36 months (for certain INDs). 
22 
eStudy Data Guidance (11)
Milestone Timetable Example 
23 
2/6/2014 
FY2017 
FY2018 
5/7/2014 
FY2015
Study Data Tech Conformance Guide 
• Guide supplements the eStudy 
guidance. 
• Provides technical recommendations / 
specs for e submission of 
standardized data in INDs, NDAs, 
ANDAs, and BLAs. 
• Consolidates Common Issues and 
Study Data Specs + much more. 
http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm 24
Study Data Tech Conformance Guide 
http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm 25
Next Steps 
• eGuidances 
– Public Comment Period ends May 7th. 
– Revise draft documents. 
– Publish final documents in FY2015. 
• Other Activities 
– XML Transport Pilot for study data 
– Testing & Acceptance project for data standards 
– TA project plan update in FY2014 
– TA development – internal and CFAST ongoing 
26
Thanks! 
Ron Fitzmartin 
ronald.fitzmartin@fda.hhs.gov 
27

More Related Content

What's hot

Metadata becomes alive via a web service between MDR and SAS
Metadata becomes alive via a web service between MDR and SASMetadata becomes alive via a web service between MDR and SAS
Metadata becomes alive via a web service between MDR and SAS
Kevin Lee
 
Standards metadata management - version control and its governance
Standards metadata management - version control and its governanceStandards metadata management - version control and its governance
Standards metadata management - version control and its governance
Kevin Lee
 
DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16
DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16
DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16
Adair Turner, MS, RAC
 
A decade of eCTD - Time to rejuvenate!
A decade of eCTD - Time to rejuvenate!A decade of eCTD - Time to rejuvenate!
A decade of eCTD - Time to rejuvenate!
Qdossier B.V.
 
Pros and cons of eCTD baseline submissions
Pros and cons of eCTD baseline submissionsPros and cons of eCTD baseline submissions
Pros and cons of eCTD baseline submissions
eCTDconsultancy
 
The Science of Submissions Part IB - How to handle grouping and worksharing i...
The Science of Submissions Part IB - How to handle grouping and worksharing i...The Science of Submissions Part IB - How to handle grouping and worksharing i...
The Science of Submissions Part IB - How to handle grouping and worksharing i...
eCTDconsultancy
 
Oracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLSOracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLS
Katalyst HLS
 
Design Considerations to Maximize Medical Device Cloud Connectivity
Design Considerations to Maximize Medical Device Cloud ConnectivityDesign Considerations to Maximize Medical Device Cloud Connectivity
Design Considerations to Maximize Medical Device Cloud Connectivity
Greenlight Guru
 
How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...
How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...
How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...
Greenlight Guru
 
Study Setup_Katalyst HLS
Study Setup_Katalyst HLSStudy Setup_Katalyst HLS
Study Setup_Katalyst HLS
Katalyst HLS
 

What's hot (10)

Metadata becomes alive via a web service between MDR and SAS
Metadata becomes alive via a web service between MDR and SASMetadata becomes alive via a web service between MDR and SAS
Metadata becomes alive via a web service between MDR and SAS
 
Standards metadata management - version control and its governance
Standards metadata management - version control and its governanceStandards metadata management - version control and its governance
Standards metadata management - version control and its governance
 
DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16
DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16
DIA_2016_Turner_ERS 2015 Lessons Learned 2.9.16
 
A decade of eCTD - Time to rejuvenate!
A decade of eCTD - Time to rejuvenate!A decade of eCTD - Time to rejuvenate!
A decade of eCTD - Time to rejuvenate!
 
Pros and cons of eCTD baseline submissions
Pros and cons of eCTD baseline submissionsPros and cons of eCTD baseline submissions
Pros and cons of eCTD baseline submissions
 
The Science of Submissions Part IB - How to handle grouping and worksharing i...
The Science of Submissions Part IB - How to handle grouping and worksharing i...The Science of Submissions Part IB - How to handle grouping and worksharing i...
The Science of Submissions Part IB - How to handle grouping and worksharing i...
 
Oracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLSOracle Clinical Overview_Katalyst HLS
Oracle Clinical Overview_Katalyst HLS
 
Design Considerations to Maximize Medical Device Cloud Connectivity
Design Considerations to Maximize Medical Device Cloud ConnectivityDesign Considerations to Maximize Medical Device Cloud Connectivity
Design Considerations to Maximize Medical Device Cloud Connectivity
 
How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...
How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...
How to Prepare for and Make the Most Out of your FDA Pre-Submission: Leverage...
 
Study Setup_Katalyst HLS
Study Setup_Katalyst HLSStudy Setup_Katalyst HLS
Study Setup_Katalyst HLS
 

Similar to Requirements for Standardized Study Data: Update on Guidance

IND and CTA Webinar slides.pptx
IND and CTA Webinar slides.pptxIND and CTA Webinar slides.pptx
IND and CTA Webinar slides.pptx
MMS Holdings
 
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.govAllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
SenseAboutSci
 
4x8 poster 07082016_2
4x8 poster 07082016_24x8 poster 07082016_2
4x8 poster 07082016_2
Helen Doughty, PMP
 
Study setup_Clinical Data Management_Katalyst HLS
Study setup_Clinical Data Management_Katalyst HLSStudy setup_Clinical Data Management_Katalyst HLS
Study setup_Clinical Data Management_Katalyst HLS
Katalyst HLS
 
Data Management Plan_Katalyst HLS
Data Management Plan_Katalyst HLSData Management Plan_Katalyst HLS
Data Management Plan_Katalyst HLS
Katalyst HLS
 
Clinical Data Management Plan_Katalyst HLS
Clinical Data Management Plan_Katalyst HLSClinical Data Management Plan_Katalyst HLS
Clinical Data Management Plan_Katalyst HLS
Katalyst HLS
 
NDA Submission Experience - Rescue Case Study
NDA Submission Experience - Rescue Case StudyNDA Submission Experience - Rescue Case Study
NDA Submission Experience - Rescue Case Study
Bhavin Busa
 
Recent and upcoming regulatory changes-TGA
Recent and upcoming regulatory changes-TGARecent and upcoming regulatory changes-TGA
Recent and upcoming regulatory changes-TGA
Razia Zahid
 
2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas
Marion Sills
 
Presentation: Medical Devices Single Audit Program (MDSAP) Pilot Program
Presentation: Medical Devices Single Audit Program (MDSAP) Pilot ProgramPresentation: Medical Devices Single Audit Program (MDSAP) Pilot Program
Presentation: Medical Devices Single Audit Program (MDSAP) Pilot Program
TGA Australia
 
Insights and Trends from 2021 FDA GCP Inspections.pptx
Insights and Trends from 2021 FDA GCP Inspections.pptxInsights and Trends from 2021 FDA GCP Inspections.pptx
Insights and Trends from 2021 FDA GCP Inspections.pptx
MMS Holdings
 
Data Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptxData Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptx
Aneesha0316
 
DATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptxDATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptx
Aneesha0316
 
Guidelines to the Preparation of document.pptx
Guidelines to the Preparation of document.pptxGuidelines to the Preparation of document.pptx
Guidelines to the Preparation of document.pptx
ShraddhaRaut43
 
What We Need to Know About CDISC
What We Need to Know About CDISCWhat We Need to Know About CDISC
What We Need to Know About CDISC
Statistics & Data Corporation
 
Shifting the goal post – from high impact journals to high impact data
 Shifting the goal post – from high impact journals to high impact data Shifting the goal post – from high impact journals to high impact data
Shifting the goal post – from high impact journals to high impact data
CGIAR Research Program on Dryland Systems
 
NSF Data Requirements and Changing Federal Requirements for Research
NSF Data Requirements and Changing Federal Requirements for ResearchNSF Data Requirements and Changing Federal Requirements for Research
NSF Data Requirements and Changing Federal Requirements for Research
Margaret Henderson
 
Clinical Trial Lecture 2-1.pdf
Clinical Trial Lecture 2-1.pdfClinical Trial Lecture 2-1.pdf
Clinical Trial Lecture 2-1.pdf
SamuelAgboola11
 
Aug2015 zivana tezak analytical validation
Aug2015 zivana tezak analytical validationAug2015 zivana tezak analytical validation
Aug2015 zivana tezak analytical validation
GenomeInABottle
 
Life Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory StrategyLife Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory Strategy
The Capital Network
 

Similar to Requirements for Standardized Study Data: Update on Guidance (20)

IND and CTA Webinar slides.pptx
IND and CTA Webinar slides.pptxIND and CTA Webinar slides.pptx
IND and CTA Webinar slides.pptx
 
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.govAllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
AllTrials AAAS 2015 - Opportunities and Challenges for ClinicalTrials.gov
 
4x8 poster 07082016_2
4x8 poster 07082016_24x8 poster 07082016_2
4x8 poster 07082016_2
 
Study setup_Clinical Data Management_Katalyst HLS
Study setup_Clinical Data Management_Katalyst HLSStudy setup_Clinical Data Management_Katalyst HLS
Study setup_Clinical Data Management_Katalyst HLS
 
Data Management Plan_Katalyst HLS
Data Management Plan_Katalyst HLSData Management Plan_Katalyst HLS
Data Management Plan_Katalyst HLS
 
Clinical Data Management Plan_Katalyst HLS
Clinical Data Management Plan_Katalyst HLSClinical Data Management Plan_Katalyst HLS
Clinical Data Management Plan_Katalyst HLS
 
NDA Submission Experience - Rescue Case Study
NDA Submission Experience - Rescue Case StudyNDA Submission Experience - Rescue Case Study
NDA Submission Experience - Rescue Case Study
 
Recent and upcoming regulatory changes-TGA
Recent and upcoming regulatory changes-TGARecent and upcoming regulatory changes-TGA
Recent and upcoming regulatory changes-TGA
 
2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas2014 0423 rqi meeting uds 2.0 and convocation project ideas
2014 0423 rqi meeting uds 2.0 and convocation project ideas
 
Presentation: Medical Devices Single Audit Program (MDSAP) Pilot Program
Presentation: Medical Devices Single Audit Program (MDSAP) Pilot ProgramPresentation: Medical Devices Single Audit Program (MDSAP) Pilot Program
Presentation: Medical Devices Single Audit Program (MDSAP) Pilot Program
 
Insights and Trends from 2021 FDA GCP Inspections.pptx
Insights and Trends from 2021 FDA GCP Inspections.pptxInsights and Trends from 2021 FDA GCP Inspections.pptx
Insights and Trends from 2021 FDA GCP Inspections.pptx
 
Data Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptxData Management Plan of Clinical Research pptx
Data Management Plan of Clinical Research pptx
 
DATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptxDATA MANAGEMENT PLAN on clinical research .pptx
DATA MANAGEMENT PLAN on clinical research .pptx
 
Guidelines to the Preparation of document.pptx
Guidelines to the Preparation of document.pptxGuidelines to the Preparation of document.pptx
Guidelines to the Preparation of document.pptx
 
What We Need to Know About CDISC
What We Need to Know About CDISCWhat We Need to Know About CDISC
What We Need to Know About CDISC
 
Shifting the goal post – from high impact journals to high impact data
 Shifting the goal post – from high impact journals to high impact data Shifting the goal post – from high impact journals to high impact data
Shifting the goal post – from high impact journals to high impact data
 
NSF Data Requirements and Changing Federal Requirements for Research
NSF Data Requirements and Changing Federal Requirements for ResearchNSF Data Requirements and Changing Federal Requirements for Research
NSF Data Requirements and Changing Federal Requirements for Research
 
Clinical Trial Lecture 2-1.pdf
Clinical Trial Lecture 2-1.pdfClinical Trial Lecture 2-1.pdf
Clinical Trial Lecture 2-1.pdf
 
Aug2015 zivana tezak analytical validation
Aug2015 zivana tezak analytical validationAug2015 zivana tezak analytical validation
Aug2015 zivana tezak analytical validation
 
Life Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory StrategyLife Science Fast Track - Regulatory Strategy
Life Science Fast Track - Regulatory Strategy
 

Recently uploaded

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
Dr. Deepika's Homeopathy - Gaur City
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
MuskanShingari
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
Dr Nitin Tyagi
 
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls LucknowCall Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
nandinirastogi03
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.GawadHemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
NephroTube - Dr.Gawad
 
Microbiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the MicroscopeMicrobiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the Microscope
ThaShee2
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and LeukotrienesPharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Dr. Nikhilkumar Sakle
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptxDistrict Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptx
CommunityMedicine46
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
Bhavyakelawadiya
 
Pharmacology of Drugs for Congestive Heart Failure
Pharmacology of Drugs for Congestive Heart FailurePharmacology of Drugs for Congestive Heart Failure
Pharmacology of Drugs for Congestive Heart Failure
Dr. Nikhilkumar Sakle
 

Recently uploaded (20)

NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
 
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls LucknowCall Girls Lucknow 9024918724 Vip Call Girls Lucknow
Call Girls Lucknow 9024918724 Vip Call Girls Lucknow
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.GawadHemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
Hemodialysis: Chapter 6, Hemodialysis Adequacy and Dose - Dr.Gawad
 
Microbiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the MicroscopeMicrobiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the Microscope
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and LeukotrienesPharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
District Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptxDistrict Residency Programme (DRP) for PGs in India.pptx
District Residency Programme (DRP) for PGs in India.pptx
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
 
Pharmacology of Drugs for Congestive Heart Failure
Pharmacology of Drugs for Congestive Heart FailurePharmacology of Drugs for Congestive Heart Failure
Pharmacology of Drugs for Congestive Heart Failure
 

Requirements for Standardized Study Data: Update on Guidance

  • 1. Requirements for Standardized Study Data: Update on Guidance Ron Fitzmartin, PhD, MBA Data Standards Program Office of Strategic Programs Center for Drug Evaluation & Research Food and Drug Administration Presented at the CSS / PhUSE Meeting Silver Spring, MD 17 March 2014
  • 2. 2 Disclaimer The views and opinions presented here represent those of the speaker and should not be considered to represent advice or guidance on behalf of the Food and Drug Administration.
  • 3. March, 2012 3 March, 2014
  • 4. 4 Road to Required Electronic Standardized Study Data
  • 5.
  • 6. 6 …no earlier than 24 months after final guidance issued after public notice” [certain] submissions shall be submitted in such electronic format as specified by the Secretary in such guidance. … the [FDA] may—provide a timetable for establishment of further standards for electronic submission as required and set forth criteria for waivers of and exemptions from the requirements. FDASIA Statute* Authorized Required Electronic Submissions CDER CBER *FDASIA: FDA Safety & Innovation Act (2012)
  • 7. FDASIA* Re-Authorized PDUFA V PDUFA V Goals –Section XII 7 “…develop standardized clinical data terminology through open standards development organizations (i.e., CDISC)” “… periodically publish final guidance specifying the completed data standards, formats, and terminologies that sponsors must use to submit data in applications.” *FDASIA: FDA Safety & Innovation Act (2012)
  • 8. Re-Designed FDA Web Page 8 Quick access to Catalog, Guidance and Tech Guide http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm
  • 9. Draft Binding Guidances & Tech Guide Published for Public Comment: 6 February 2014 http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm 9
  • 10. What is Binding Guidance? 10 Guidance = Binding Guidance = “Please” • Recommends, • Suggests, • Encourages • Requires Do it! Binding Guidance has a bite!
  • 11. • Submission types: – NDAs, ANDAs, Certain BLAs & INDs • Submission not in the electronic format(s) specified in guidance will not be filed. • Electronic submissions are required no earlier than 24 months after a final guidance is issued. • Individual draft guidances will be developed. 11 FDASIA 745A(a) Guidance (1)
  • 12. • Electronic submission of standardized study data required for: – Certain INDs – NDAs – ANDAs – Certain BLAs • Including amendments, supplements, and reports 12 eStudy Data Guidance (1)
  • 13. • Study data must be submitted electronically or it will not be filed…unless exempt: – Devices regulated by CBER as biological products under Section 351 of the PHS Act – Study data in noncommercial INDs (e.g., investigator-sponsored INDs, emergency use INDs, and treatment INDs). 13 eStudy Data Guidance (2)
  • 14. • What are the requirements for Standardized Study Data? – Must be in a format that FDA can process, review, and archive. – Formats listed in the Data Standards Catalog (DSC). – DSC lists the supported and/or required standards. – DSC lists key dates for each standard. 14 eStudy Data Guidance (3) http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm
  • 15. • What are the requirements for Standardized Study Data? – DSC lists (or will) dates when: • Support begins and ends • Requirement begins and ends • FDA may Refuse To File – If study data do not conform to the required standards, formats, and terminologies. 15 eStudy Data Guidance (4) http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm
  • 16. Data Standards Catalog 16 eStudy Data Guidance (5) Dates: Requirement Begins & Ends
  • 17. • Will there be waivers from the requirement? – No. – However, waivers may be granted to use specific (e.g., retired) versions of standards listed in the Data Catalog. 17 eStudy Data Guidance (6)
  • 18. • Initial Timetable for Requirements – NDAs, ANDAs, certain BLA Submissions • Studies that start 24 months after publication of final eStudy Guidance. – Start Date defined as by CDISC SDTM Trial Summary Domain • Studies must use the standards, formats, terminologies posted in Data Standards Catalog. – Certain IND Submissions • Studies that start 36 months after publication of final eStudy Guidance. 18 eStudy Data Guidance (7)
  • 19. • Initial Timetable for Requirement – Example – November 15, 2014 - Federal Register Notice of final eStudy Guidance • #1- Sponsor starts a study October 22, 2016 – Submission of Standardized Study Data not required (but recommended) for that study. • #2- Sponsor starts a study December 3, 2016 – Submission of Standardized Study Data will be required for that study. – Must use FDA-supported standards, formats and terminologies specified in the Data Standards Catalog. 19 eStudy Data Guidance (8)
  • 20. • Version Updates – Types • Content or structural changes (e.g., new SDTM domains or variables). • Typographical errors, corrections, or clarifications. – Federal Register notice will specify the effective date and will correspond to a specific calendar month, e.g., March. – Required in submissions for studies starting no earlier than 12 months after the Federal Register notice. 20 eStudy Data Guidance (9)
  • 21. • Version Updates – Example – May 6, 2016, Federal Register notice - support for new version, SDTM 4.1, and update to the Data Standards Catalog. • Effective date posted in the Federal Register notice is March 15, 2017. • Required in submissions for studies that start after March 15, 2018. • The Data Standards Catalog will list March 15, 2018 as the “date requirement begins.” 21 eStudy Data Guidance (10)
  • 22. • New Standards – New standards, formats and terminologies • Not supported by FDA and • Not listed in the Data Standards Catalog when Guidance is final. – After notice in the Federal Register, required in submissions for studies that start • 24 months (NDAs, ANDAs, and certain BLAs) and • 36 months (for certain INDs). 22 eStudy Data Guidance (11)
  • 23. Milestone Timetable Example 23 2/6/2014 FY2017 FY2018 5/7/2014 FY2015
  • 24. Study Data Tech Conformance Guide • Guide supplements the eStudy guidance. • Provides technical recommendations / specs for e submission of standardized data in INDs, NDAs, ANDAs, and BLAs. • Consolidates Common Issues and Study Data Specs + much more. http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm 24
  • 25. Study Data Tech Conformance Guide http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm 25
  • 26. Next Steps • eGuidances – Public Comment Period ends May 7th. – Revise draft documents. – Publish final documents in FY2015. • Other Activities – XML Transport Pilot for study data – Testing & Acceptance project for data standards – TA project plan update in FY2014 – TA development – internal and CFAST ongoing 26
  • 27. Thanks! Ron Fitzmartin ronald.fitzmartin@fda.hhs.gov 27